Thank you, Mr. Speaker. We have developed a steering committee, as the Member mentioned in her Member's statement, to review options around prescription drug monitoring, and we've asked them to come back with recommendations on best approaches that would be appropriate here in the Northwest Territories. We do know that the most effective monitoring method needs to be consistent with the department's emerging suite of e-Health tools, such as electronic medical records. At this time, there have not been any final recommendations provided by the committee on how to improve or implement a prescription drug monitoring program. However, it is still our intent, and we are still moving forward with that work to help curb prescription drug abuse here in the Northwest Territories and help us advance the design of a monitoring program. However, given our current fiscal environment, it's not possible to state with any certainty when this will be able to move forward, but we are committed to moving forward and we are committed to getting that work done. Thank you, Mr. Speaker.